122P Practice patterns and treatment outcomes of molecular tumour board (MTB)-based personalized cancer therapies: A single-center experience
Florian Moik(Medical University of Graz), Philipp J. Jost(Medical University of Graz), Samantha O. Hasenleithner(Medical University of Graz), Tamara Esterl(Medical University of Graz), Karl Kashofer(Medical University of Graz), Leo Edlinger(University of Veterinary Medicine Vienna), Armin Gerger(Medical University of Graz), Ellen Heitzer(Medical University of Graz), Gerald Höefler(Medical University of Graz), Margit Zacharias(Auguste-Viktoria-Klinik), S. Kostmann(Medical University of Graz), Jakob M. Riedl(Medical University of Graz), L. Cebular(Medical University of Graz), Sarah Jahn(Medical University of Graz)
Cited by 0
Related Papers
Cognitive impairment by antibiotic-induced gut dysbiosis: Analysis of gut microbiota-brain communication
|Brain Behavior and Immunity|2016|741
Human platelet lysate can replace fetal bovine serum for clinical‐scale expansion of functional mesenchymal stromal cells
|Transfusion|2007|507
Inferring expressed genes by whole-genome sequencing of plasma DNA
|Nature Genetics|2016|463
Molecular epidemiology and diagnostics of KRAS mutations in human cancer
|Cancer and Metastasis Reviews|2020|334